- Home
- CGTX vs ORMP Comparison
CGTX vs ORMP Comparison
Compare CGTX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGTX | ORMP |
|---|---|---|
| Founded | 2007 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.4M | 117.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGTX | ORMP |
|---|---|---|
| Price | $1.10 | $3.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.33 | N/A |
| AVG Volume (30 Days) | ★ 992.5K | 324.5K |
| Earning Date | 03-19-2026 | 11-13-2025 |
| Dividend Yield | N/A | ★ 7.42% |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.28 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $1.82 |
| 52 Week High | $3.83 | $3.71 |
Technical Indicators
Market Signals| Indicator | CGTX | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 30.21 | 53.36 |
| Support Level | $1.37 | $3.33 |
| Resistance Level | $1.49 | $3.60 |
| Average True Range (ATR) | 0.09 | 0.21 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 4.60 | 19.05 |
Price Performance
Historical ComparisonAbout CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.